港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

药明合联

62.250

+4.0506.96%

成交量：565.03万

成交额：3.43亿

市值：783.11亿

市盈率：48.84

高：62.550

开：59.950

低：58.400

收：58.200

52周最高：85.500

52周最低：24.700

股本：12.58亿

香港流通股本：12.58亿

量比：2.07

换手率：0.45%

股息：- -

股息率：- -

每股收益(LYR):1.275

净资产收益率：17.05%

总资产收益率：8.60%

市净率：6.42

市盈率(LYR):48.84

市销率: 11.58

数据加载中...

总览公司新闻资讯公告

【券商聚焦】招银国际：AI将改变创新药物研发范式

《大行》交银国际：药明合联(02268.HK)全球CXO赛道投融资、BD交易延续高活跃度维持“买入”评级

阿斯达克财经

《大行》大摩：药明合联(02268.HK)股价未来30日将绝对上涨

阿斯达克财经

药明合联与Earendil Labs就Wuxitecan-2有效载荷-连接子技术平台达成战略合作

药明合联与Earendil Labs就WuXiTecan-2载荷连接子技术授权达成战略合作

药明合联午前涨近8% 公司有望持续受益XDC CRDMO行业下游需求改善趋势

【券商聚焦】交银国际：2026年医药板块稳中向好态势或将延续但仍有短期波动可能

【券商聚焦】交银国际维持药明合联(02268)买入评级指XDC赛道融资/BD开年延续较高热情

港股创新药概念股走强！药明合联涨超7%，云顶新耀、再鼎医药涨近6%

老虎资讯综合

药明合联02月26日主力净流出958.1万元散户资金买入

药明合联盘中异动大幅跳水5.01%报60.700港元

每日卖空追踪 | 药明合联 02月25日卖空量成交32.9万股，卖空比例为16.42%

每日卖空追踪 | 药明合联 02月23日卖空量成交11.3万股，卖空比例为10.52%

【国联民生医药】医药周报20260223：春节期间医药行业重点事件梳理

医耀科技创新骑手

《大行》大摩降药明合联(02268.HK)目标价至86元评级“增持”

阿斯达克财经

药明合联(02268)出现大手卖出11.95万股，成交价$64.95，涉资776.152万

阿斯达克财经

药明合联02月16日遭主力抛售211.9万元

每日卖空追踪 | 药明合联 02月12日卖空量成交25.95万股，卖空比例为6.27%

《大行》野村升药明合联(02268.HK)目标价至87.73元料今年盈利升47%

阿斯达克财经

药明合联(2268)、东曜药业(1875)联合公告：寄发自愿有条件现金要约综合文件

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02268/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":62.25,"timestamp":1775021216988,"preClose":58.2,"halted":0,"volume":5650257,"delay":0,"changeRate":0.06958762886597933,"floatShares":1258000000,"shares":1258000000,"eps":1.274507350438136,"marketStatus":"交易中","change":4.05,"latestTime":"04-01 13:27:00","open":59.95,"high":62.55,"low":58.4,"amount":342661304,"amplitude":0.071306,"askPrice":62.25,"askSize":19000,"bidPrice":62.15,"bidSize":14000,"shortable":3,"etf":0,"ttmEps":1.2726149329236751,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1775031000000},"marketStatusCode":2,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":58.2,"openAndCloseTimeList":[[1775007000000,1775016000000],[1775019600000,1775030400000]],"volumeRatio":2.066095,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1258000000,"roa":"8.60%","roe":"17.05%","lyrEps":1.274507,"volumeRatio":2.066095,"shares":1258000000,"dividePrice":0,"high":62.55,"amplitude":0.071306,"preClose":58.2,"low":58.4,"week52Low":24.7,"pbRate":"6.42","psRate":"11.58","week52High":85.5,"institutionHeld":0,"latestPrice":62.25,"committee":-0.151515,"eps":1.274507350438136,"divideRate":0,"volume":5650257,"delay":0,"ttmEps":1.2726149329236751,"open":59.95,"prevYearClose":60.75,"prevWeekClose":58.9,"prevMonthClose":58.2,"prevQuarterClose":58.2,"fiveDayClose":57.1,"twentyDayClose":56,"sixtyDayClose":61.35,"earningDate":1777392000000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2026-04-29","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777426200000,"name":null,"time":"","dateTimestamp":1777392000000,"actualEps":null},{"date":"2026-03-23","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-18","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":21,"updateTime":1774627200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2026-03-31","current":48.00845,"percent":0.171527,"low":30.568632,"twenty":44.640826,"median":58.216709,"eighty":71.359507,"high":153.052589,"avg":63.752689,"sd":26.124998,"marketCap":73215175431},"quantilePoints":[{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191},{"date":"2025-04-11","current":35.581021,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":40380451549},{"date":"2025-04-17","current":33.597127,"twenty":0.4381,"median":49.700845,"eighty":72.980467,"marketCap":38220427395},{"date":"2025-04-25","current":39.226609,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44663120338},{"date":"2025-05-02","current":40.829264,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":46586700218},{"date":"2025-05-09","current":38.818219,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44603008467},{"date":"2025-05-16","current":39.608151,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":45882474676},{"date":"2025-05-23","current":38.196121,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44379117053},{"date":"2025-05-30","current":41.172242,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48047309655},{"date":"2025-06-06","current":42.866418,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":50152010328},{"date":"2025-06-13","current":46.041552,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":53888090995},{"date":"2025-06-20","current":41.240748,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48174509918},{"date":"2025-06-27","current":40.971553,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":47994081042},{"date":"2025-07-04","current":46.000985,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":53888090995},{"date":"2025-07-11","current":47.288014,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":55339986740},{"date":"2025-07-18","current":50.925924,"twenty":0.438098,"median":50.569275,"eighty":72.98104,"marketCap":59550637905},{"date":"2025-07-25","current":57.660678,"twenty":0.438098,"median":51.683826,"eighty":72.98104,"marketCap":67671179437},{"date":"2025-08-01","current":57.245588,"twenty":0.438098,"median":52.545804,"eighty":72.98104,"marketCap":66768897045},{"date":"2025-08-08","current":57.73965,"twenty":0.43811,"median":53.257543,"eighty":72.98104,"marketCap":67513611340},{"date":"2025-08-15","current":64.222783,"twenty":31.309336,"median":54.856958,"eighty":72.98104,"marketCap":74981664691},{"date":"2025-08-22","current":48.130228,"twenty":34.419063,"median":54.952855,"eighty":72.98104,"marketCap":69501077151},{"date":"2025-08-29","current":46.988345,"twenty":35.581021,"median":54.952855,"eighty":72.98104,"marketCap":68176099944},{"date":"2025-09-05","current":54.370406,"twenty":36.186031,"median":55.113399,"eighty":72.98104,"marketCap":78808670381},{"date":"2025-09-12","current":57.034752,"twenty":36.596757,"median":55.50873,"eighty":72.98104,"marketCap":82819396110},{"date":"2025-09-19","current":59.571504,"twenty":36.911418,"median":56.000464,"eighty":72.98104,"marketCap":86441593568},{"date":"2025-09-26","current":63.204858,"twenty":37.279949,"median":56.495601,"eighty":72.98104,"marketCap":91475834102},{"date":"2025-10-03","current":72.025865,"twenty":37.670679,"median":56.699916,"eighty":72.980467,"marketCap":104491187679},{"date":"2025-10-10","current":60.90024,"twenty":38.189538,"median":56.97042,"eighty":72.98104,"marketCap":88221995708},{"date":"2025-10-17","current":57.936353,"twenty":38.732076,"median":57.121577,"eighty":72.98104,"marketCap":83863080123},{"date":"2025-10-24","current":59.821834,"twenty":39.226609,"median":57.526112,"eighty":72.98104,"marketCap":86623810506},{"date":"2025-10-31","current":63.630196,"twenty":39.774995,"median":57.92353,"eighty":72.98104,"marketCap":92275860553},{"date":"2025-11-07","current":58.827143,"twenty":40.354886,"median":58.251953,"eighty":72.98104,"marketCap":85257233036},{"date":"2025-11-14","current":59.953959,"twenty":41.172242,"median":58.455089,"eighty":72.98104,"marketCap":87136525462},{"date":"2025-11-21","current":57.356344,"twenty":41.596291,"median":58.554061,"eighty":72.98104,"marketCap":83322340564},{"date":"2025-11-28","current":56.291024,"twenty":42.018405,"median":58.564991,"eighty":72.98104,"marketCap":82071768197},{"date":"2025-12-05","current":57.95451,"twenty":42.42494,"median":58.564991,"eighty":72.98104,"marketCap":84642388897},{"date":"2025-12-12","current":56.819112,"twenty":42.866418,"median":58.860686,"eighty":72.98104,"marketCap":83137635317},{"date":"2025-12-19","current":59.902097,"twenty":43.024716,"median":58.930609,"eighty":72.98104,"marketCap":87855221510},{"date":"2025-12-24","current":53.787136,"twenty":43.211711,"median":58.930609,"eighty":72.98104,"marketCap":79132453088},{"date":"2026-01-02","current":52.131715,"twenty":43.875774,"median":58.940897,"eighty":73.022778,"marketCap":76998826280},{"date":"2026-01-09","current":60.097118,"twenty":44.079539,"median":58.920321,"eighty":72.979321,"marketCap":88984788643},{"date":"2026-01-16","current":59.868148,"twenty":44.329264,"median":59.011667,"eighty":72.978748,"marketCap":88933823858},{"date":"2026-01-23","current":58.064858,"twenty":44.542103,"median":59.011667,"eighty":72.978748,"marketCap":86172293688},{"date":"2026-01-30","current":52.991062,"twenty":44.673253,"median":58.945496,"eighty":72.939295,"marketCap":79001941874},{"date":"2026-02-06","current":53.067413,"twenty":44.72485,"median":58.907275,"eighty":72.769063,"marketCap":79316440050},{"date":"2026-02-13","current":54.647287,"twenty":44.764796,"median":58.707371,"eighty":72.713983,"marketCap":82146923636},{"date":"2026-02-20","current":54.893728,"twenty":44.79956,"median":58.576126,"eighty":72.595053,"marketCap":82398522177},{"date":"2026-02-27","current":52.350133,"twenty":44.938454,"median":58.531174,"eighty":72.112603,"marketCap":79442239320},{"date":"2026-03-06","current":49.767005,"twenty":45.116803,"median":58.469542,"eighty":72.01889,"marketCap":74913465582},{"date":"2026-03-13","current":45.00506,"twenty":45.116803,"median":58.377121,"eighty":71.985255,"marketCap":68057405340},{"date":"2026-03-20","current":44.215816,"twenty":45.114658,"median":58.350601,"eighty":71.8872,"marketCap":66610713729},{"date":"2026-03-27","current":44.200592,"twenty":44.738431,"median":58.251953,"eighty":71.510989,"marketCap":74095770324},{"date":"2026-03-31","current":43.507132,"twenty":44.640826,"median":58.216709,"eighty":71.359507,"marketCap":73215175431}],"updateTime":1775015454709},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616538865","title":"【券商聚焦】招银国际：AI将改变创新药物研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538865","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616538865?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 14:40","pubTimestamp":1772433633,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨5.0%，跑赢MSCI中国指数6.2%。医药行业近期明显回调（MSCI中国医疗指数1月15日至今累计下跌9%），特别是创新药板块回调幅度较大（恒生生物科技指数1月15日至今累计下跌13%）。该机构认为，此轮调整原因包括博弈层面行业短期缺乏催化剂，以及行业轮动导致资金流出医药板块。中国创新药资产出海BD持续超预期，MNC对于中国资产的购买范围从单个管线拓宽至平台合作，进一步体现了中国创新药的竞争力。该机构认为，中国的AI制药技术发展迅猛，将涌现一批优秀的创新企业。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","01789","LU0348827113.USD","06978","LU1720050803.USD","SG9999014674.SGD","LU1303224171.USD","LU0588546209.SGD","LU2488822045.USD","LU0307460666.USD","BK1100","BK1585","LU0348784397.USD","LU1961090484.USD","LU1794554557.SGD","LU1115378108.SGD","IE00B543WZ88.USD","LU0348783233.USD","LU2399975544.HKD","BK1617","LU2328871848.SGD","BK1161","03933","SG9999004311.SGD","01099","02196","HK0000165453.HKD","LU1969619763.USD","BK1583","159992","BK1574","BK1141","IE00BPRC5H50.USD","LU2476274720.SGD","06160","LU1251922891.USD","BK1515","LU0634319403.HKD","02228","LU0348735423.USD","LU0640798160.USD","02367","02268","09688","09926","BK1197","IE00B5MMRT66.SGD","BK1207","LU0561508036.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616800129","title":"《大行》交银国际：药明合联(02268.HK)全球CXO赛道投融资、BD交易延续高活跃度 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2616800129","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616800129?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 14:09","pubTimestamp":1772431740,"startTime":"0","endTime":"0","summary":"交银国际研究报告指出，药明合联作为反映CRDMO业务需求的先行指标，全球CXO赛道的投融资和BD交易在2026年初延续了过去两年的极高活跃度。交银国际的目标价为91港元，对应2026年市盈率42倍，维持“买入”评级，考虑到公司在高景气度的XDC CRDMO赛道中稳居全球领先地位、当前投资性价比极高，继续将公司选为CXO行业重点推荐标的。沽空资料截至 2026-03-02 12:25。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104105862_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104105862_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505890/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505890/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616580103","title":"《大行》大摩：药明合联(02268.HK)股价未来30日将绝对上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2616580103","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616580103?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 11:58","pubTimestamp":1772423880,"startTime":"0","endTime":"0","summary":"摩根士丹利发表技术意见报告，相信药明合联(02268.HK) 股价在未来30日将绝对上涨，主要是该股近期交易价格下跌，令短期估值更具吸引力。药明康德宣布一项涉及其有效载荷连接子技术平台的规模可观的对外授权协议。此类协议包括预付款、里程碑付款以及潜在的销售分成，这些都将有助于提升销售额和盈利能力。该行给予药明合联目标价为86元，其评级为“增持”。(ca/w)(港股报价延迟最少十五分钟。沽空资料截至 2026-02-27 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505845/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505845/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["SG9999014674.SGD","LU2488822045.USD","02268","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193991119","title":"药明合联与Earendil Labs就Wuxitecan-2有效载荷-连接子技术平台达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1193991119","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193991119?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 17:14","pubTimestamp":1772183652,"startTime":"0","endTime":"0","summary":"药明合联（WuXi XDC）宣布与Earendil Labs建立战略合作伙伴关系，双方将围绕Wuxitecan-2有效载荷-连接子技术平台展开深度协作。此次合作旨在整合彼此在生物偶联技术领域的优势资源，共同推进新型抗体偶联药物（ADC）技术的开发与应用。\n通过本次战略联手，药明合联将借助Earendil Labs在创新有效载荷-连接子技术方面的专长，进一步拓展其ADC技术平台的能力边界。Wuxitecan-2作为新一代拓扑异构酶I抑制剂有效载荷，具有显著的治疗潜力，这项合作将加速其在癌症治疗领域的创新应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU2488822045.USD","SG9999014674.SGD","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614154831","title":"药明合联与Earendil Labs就WuXiTecan-2载荷连接子技术授权达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2614154831","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614154831?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 17:11","pubTimestamp":1772183460,"startTime":"0","endTime":"0","summary":"上海2026年2月27日 /美通社/ -- 全球领先的专注于提供抗体偶联药物等生物偶联药物端到端CRDMO服务的药明合联，今日宣布与Earendil Labs就药明合联自主研发的WuXiTecan-2载荷连接子技术授权达成战略合作。Earendil Labs利用其独特的AI平台生成了具有差异化优势的双特异性抗体，与我们的WuXiTecan-2载荷连接子技术联用，有望开发出更有效、更安全的下一代ADC药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4897609_ZH97609_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614045007","title":"药明合联午前涨近8% 公司有望持续受益XDC CRDMO行业下游需求改善趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045007","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045007?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 11:55","pubTimestamp":1772164500,"startTime":"0","endTime":"0","summary":"　　药明合联盘中涨超8%，截至发稿，股价上涨7.54%，现报62.75港元，成交额3.01亿港元。2024年年初以来，XDC领域投融资事件数、BD交易数和首付款总额呈逐步上升态势。投融资和BD交易持续活跃，将进一步拉动XDC CRDMO行业下游需求改善，药明合联作为技术实力和一体化交付能力布局的龙头企业，有望持续受益于这一重要趋势、并扩大市场份额。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-02-27/doc-inhpfnzn6798937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2488822045.USD","02268","SG9999014674.SGD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614009267","title":"【券商聚焦】交银国际：2026年医药板块稳中向好态势或将延续 但仍有短期波动可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009267","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614009267?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 09:45","pubTimestamp":1772156713,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周2026ASCOGU大会常规摘要公布，此次大会将于本月2628号召开，共有超过70项我国专家主导的研究入选，荣昌、翰森、科伦博泰、映恩生物等中国创新药企将携重磅数据亮相，临床数据密集释放有望阶段性催化板块行情。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU1770034418.SGD","01530","159938","LU0348827113.USD","02196","LU0640798160.USD","LU1720050803.USD","BK1147","02268","LU0348825331.USD","LU0417516902.SGD","02367","LU0417516738.SGD","LU2476274308.USD","IE00B543WZ88.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0540923850.HKD","09926","BK1141","BK1588","LU0348766576.USD","03933","02228","03329","LU0588546209.SGD","LU1961090484.USD","LU2399975544.HKD","BK1617","LU2476274720.SGD","LU2488822045.USD","01789","BK1191","LU0348767384.USD","BK1100","BK1197","09688","SG9999014674.SGD","01099","LU2778985437.USD","BK1207","LU0634319403.HKD","09939","BK1161","LU1251922891.USD","06160","LU0348784397.USD","LU0417516571.SGD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614697009","title":"【券商聚焦】交银国际维持药明合联(02268)买入评级 指XDC赛道融资/BD开年延续较高热情","url":"https://stock-news.laohu8.com/highlight/detail?id=2614697009","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614697009?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 09:43","pubTimestamp":1772156610,"startTime":"0","endTime":"0","summary":"2024年年初以来，XDC领域投融资事件数、BD交易数和首付款总额呈逐步上升态势。投融资和BD交易持续活跃，将进一步拉动XDC CRDMO行业下游需求改善，药明合联作为技术实力和一体化交付能力布局的龙头企业，有望持续受益于这一重要趋势、并扩大市场份额。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975587","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128119023","title":"港股创新药概念股走强！药明合联涨超7%，云顶新耀、再鼎医药涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128119023","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128119023?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 09:40","pubTimestamp":1772156400,"startTime":"0","endTime":"0","summary":"2月27日，港股创新药概念股走强，$药明合联(02268)$涨超7%，$云顶新耀(01952)$、$再鼎医药(ZLAB)$涨近6%，$康方生物(09926)$、$药明生物(02269)$涨超4%，$歌礼制药-B(01672)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9a5adfc15d956a00313fe91052a1cff8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1141","BK4526","ZLAB","BK4588","BK1588","LU2488822045.USD","09688","01952","VXUS","BK1583","BK4531","VT","02268","BK1574","159992","BK4139","06978","BK1161","SG9999014674.SGD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614567008","title":"药明合联02月26日主力净流出958.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614567008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614567008?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 16:15","pubTimestamp":1772093752,"startTime":"0","endTime":"0","summary":"02月26日, 药明合联股价跌8.69%，报收58.35元，成交金额5.0亿元，换手率0.66%，振幅10.41%，量比3.95。药明合联今日主力资金净流出958.1万元，上一交易日主力净流入335.0万元。该股近5个交易日下跌10.08%，主力资金累计净流出1675.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5857.5万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162012a4caa49b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162012a4caa49b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","LU2488822045.USD","BK1141","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614008526","title":"药明合联盘中异动 大幅跳水5.01%报60.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614008526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614008526?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 14:06","pubTimestamp":1772085973,"startTime":"0","endTime":"0","summary":"2026年02月26日下午盘14时06分，药明合联股票出现波动，股价大幅下挫5.01%。截至发稿，该股报60.700港元/股，成交量429.846万股，换手率0.34%，振幅5.71%。资金方面，该股资金流入9895.07万港元，流出1.2869亿港元。药明合联股票所在的生物技术行业中，整体跌幅为3.94%。其相关个股中，百奥赛图-B、药捷安康-B、思路迪医药股份涨幅较大，振幅较大的相关个股有三叶草生物-B、百奥赛图-B、药捷安康-B，振幅分别为11.96%、11.38%、9.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226140613a4ca28ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226140613a4ca28ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","BK1141","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614081032","title":"每日卖空追踪 | 药明合联 02月25日卖空量成交32.9万股，卖空比例为16.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614081032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614081032?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 16:30","pubTimestamp":1772008232,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月25日，跌1.01%，卖空量成交32.9万股，较上一交易日减少68.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163414a71d5a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163414a71d5a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU2488822045.USD","SG9999014674.SGD","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613875532","title":"每日卖空追踪 | 药明合联 02月23日卖空量成交11.3万股，卖空比例为10.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613875532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613875532?lang=zh_cn&edition=fundamental","pubTime":"2026-02-23 16:30","pubTimestamp":1771835429,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月23日，涨2.21%，卖空量成交11.3万股，较上一交易日减少65.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163343a4be7d73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163343a4be7d73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613204910","title":"【国联民生医药】医药周报20260223：春节期间医药行业重点事件梳理","url":"https://stock-news.laohu8.com/highlight/detail?id=2613204910","media":"医耀科技创新骑手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613204910?lang=zh_cn&edition=fundamental","pubTime":"2026-02-23 14:18","pubTimestamp":1771827529,"startTime":"0","endTime":"0","summary":"1春节期间医药行业重点事件梳理1.1创新药BD交易实现开门红，优势产品海外研发和注册进展顺利2026年春节前后，中国创新药对外BD交易实现开门红，全年交易金额有望再攀新高。根据医药魔方，截至2026年2月15日，中国创新药2026年对外BD交易首付款规模超过2025年任一季度，总金额超过2025年全年水平的1/3。3）2月17日，石药集团发布公告，SYH2082的临床试验申请获得FDA批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223142808a71517c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223142808a71517c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1147","01530","02228","06938","09939","BK1515","02268","03759","01801","02155","02252","BK1161","BK1564","09606","01456","09995","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612581462","title":"《大行》大摩降药明合联(02268.HK)目标价至86元  评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2612581462","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612581462?lang=zh_cn&edition=fundamental","pubTime":"2026-02-20 10:19","pubTimestamp":1771553940,"startTime":"0","endTime":"0","summary":"摩根士丹利发表研究报告指出，鉴于药明合联(02268.HK) 早前披露2025年初步业绩，因经营利润率下降，该行将其2026至2030年盈利预测下调1%至2%，目标价亦相应下调2%，由88元降至86元。此外，该行预测药明合联2024至2027年的经调整净利润的年均复合增长率达36%，远高于全球同业，予其“增持”评级，看好公司盈利增长及可见性较高、毛利扩张潜力，以及行业领导地位。(jl/u)(港股报价延迟最少十五分钟。沽空资料截至 2026-02-16 12:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1503868/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1503868/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612230586","title":"药明合联(02268)出现大手卖出11.95万股，成交价$64.95，涉资776.152万","url":"https://stock-news.laohu8.com/highlight/detail?id=2612230586","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612230586?lang=zh_cn&edition=fundamental","pubTime":"2026-02-20 09:35","pubTimestamp":1771551300,"startTime":"0","endTime":"0","summary":"[大手成交]药明合联(02268)在上午09:35出现大手卖出，成交量为11.95万，成交价为港币$64.95，涉资776.152万。至目前为止，股价无升跌，今日最高价为$66.15，而最低价为$64.95，总成交量为22.25万股，总成交金额港币$1.446千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2602201007/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2602201007/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612847734","title":"药明合联02月16日遭主力抛售211.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612847734","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612847734?lang=zh_cn&edition=fundamental","pubTime":"2026-02-16 16:15","pubTimestamp":1771229731,"startTime":"0","endTime":"0","summary":"02月16日, 药明合联股价跌0.46%，报收65.00元，成交金额5556.5万元，换手率0.07%，振幅2.45%，量比0.20。药明合联今日主力资金净流出211.9万元，上一交易日主力净流出960.0万元。该股近5个交易日上涨3.59%，主力资金累计净流出1103.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出2520.9万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161642a700d466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161642a700d466&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610926836","title":"每日卖空追踪 | 药明合联 02月12日卖空量成交25.95万股，卖空比例为6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610926836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610926836?lang=zh_cn&edition=fundamental","pubTime":"2026-02-12 16:30","pubTimestamp":1770885029,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月12日，跌1%，卖空量成交25.95万股，较上一交易日减少64.93%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163402a49b9f7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163402a49b9f7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","02268","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610992686","title":"《大行》野村升药明合联(02268.HK)目标价至87.73元 料今年盈利升47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610992686","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610992686?lang=zh_cn&edition=fundamental","pubTime":"2026-02-12 11:33","pubTimestamp":1770867180,"startTime":"0","endTime":"0","summary":"野村将药明合联2025年收入及盈利预测分别下调4.5%及8.7%，以反映公司上月公布的实际数据。同时，该行预计来自商业化阶段项目的收入为1.81亿元，而收购东曜药业带来的收入则为1.5亿元。利润方面，该行料2026年盈利将升47%；毛利率按年扩张0.7个百分点至36.5%，基于规模经济效应，但新加坡厂房的折旧将带来轻微拖累；经营利润率按年扩张1.1个百分点至29.3%，反映效率提升。该行将药明合联目标价由82.72港元升至87.73港元，予“买入”评级。沽空资料截至 2026-02-11 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1502911/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1502911/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144275849","title":"药明合联(2268)、东曜药业(1875)联合公告：寄发自愿有条件现金要约综合文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1144275849","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144275849?lang=zh_cn&edition=fundamental","pubTime":"2026-02-12 06:52","pubTimestamp":1770850322,"startTime":"0","endTime":"0","summary":"药明合联生物技术有限公司与东曜药业股份有限公司于2026年2月12日联合发布公告，宣布寄发有关自愿有条件现金要约的综合文件。该要约由花旗环球金融亚洲有限公司代表要约人，拟收购除要约人及其一致行动人士已拥有或同意收购以外的全部已发行股份，并注销全部尚未行使的购股权。综合文件包含要约详情、独立董事委员会及独立财务顾问意见、接受程序及预期时间表等内容。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}